The α-1,3-galactosyltransferase knockout mouse: Implications for xenotransplantation

Transplantation

Volumn 61, Issue 1, 1996, Pages 13-19

  Tearle, Rick G ^b   Tange, Margaret J ^a   Zannettino, Zara L ^b   Katerelos, Marina ^a   Shinkel, Trixie A ^a   Van Denderen, Bryce J W ^a   Lonie, Andrew J ^b   Lyons, Ian ^b   Nottle, Mark B ^b   Cox, Timothy ^b   Becker, Christiane ^b   Peura, Anita M ^b   Wigley, Peter L ^b   Craword, Robert J ^b   Robins, Allan J ^b   Pearse, Martin J ^a   D'Apice, Anthony J F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b Bresatec Limited   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GALACTOSYLTRANSFERASE; GLYCOLIPID; GLYCOPROTEIN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; GENE REPRESSION; GENE TARGETING; GRAFT REJECTION; HUMAN; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; EPITOPES; GALACTOSYLTRANSFERASES; HUMANS; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; SPECIES SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 9044248239     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601150-00004     Document Type: Article

References (25)

1. Auchincloss H. Xenogeneic transplantation. Transplantation 1988; 46: 1.
2. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
3. McCurry KR, Kooyman DL, Diamond LE, et al. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs. Transplant Proc 1995; 27: 317.
4. Platt JL, Vercellotti GM, Lindman B, Oegema TR Jr, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171: 1363.
5. Galili U, Shohet SB, Korbin E, Stults CLM, Macher BA. Man, apes and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755.
6. Sandrin MS, Vaughan HA, Dabkowski PL, Mckenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal(α1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
7. Cooper DKC, Good AH, Koren E, et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993; 1: 198.
8. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
9. Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between natural anti-Gal antibody and the Gal α1-3 Gal epitope in primates. Proc Natl Acad Sci USA 1987; 84: 1369.
10. Galili U, Swanson K. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 1991; 88: 7401.
11. Galili U, Mandrell RE, Hamedeh RM, Shohet SB, Griffiths JM. Interaction between natural anti-α-galactosyl immunoglobulin G and bacterial of the human flora. Immun Infect 1988; 56: 1730.
12. Neethling FA, Koren E, Ye Y, et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by alpha-galactosyl oligosaccharides. Transplantation 1994; 57: 959.
13. Vaughan HA, Loveland BE, Sandrin MS. Gal alpha(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies. Transplantation 1994; 58: 879.
14. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes - a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
15. Galili U. Significance of natural the human anti-gal antibody in xenotransplantation. Xeno 1994; 2: 84.
16. O'Gorman S, Fox DT, Wahl GM. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 1991; 251: 1351.
17. Mann GB, Fowler KJ, Grail D, Dunn AR. Identification of germline chimeras by polymerase chain reaction and isoenzyme analysis of mouse spermatozoa. J Reprod Fertil 1993; 99: 505.
18. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153.
19. Langford GA, Yannoutsos N, Cozzi E, et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26: 1400.
20. Cozzi E, Langford GA, Richards A, et al. Expression of human decay accelerating factor in transgenic rigs. Transplant Proc 1994; 26: 1402.
21. Cooper DKC, Koren E, Oriol R. Genetically engineered pigs. Lancet 1993; 342: 682.
22. Sandrin MS, Vaughan HA, Mckenzie IFC. Identification of Gal(α1,3) Gal as the major epitope for pig-to-human vascularised xenografts. Transplant Rev 1994; 8: 134.
23. West JD, Fisher G. Inherited cataracts in inbred mice. Genet Res 1985; 46: 45.
24. Samuelsson BE, Rydberg L, Breimer ME, et al. Natural antibodies and human xenotransplantation. Immunol Rev 1994; 141: 151.
25. Collins BH, Parker W, Platt JL. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation 1994; 1: 36.